The landscape of reproductive health is evolving rapidly, with growing concerns about data privacy and access to unbiased healthcare information, underscoring the importance of modernizing reproductive health care.

In response to these challenges, Comma, a female-founded integrated period care company, is stepping up with innovative solutions.

The Nashville-based company recently announced a $2 million seed funding round alongside the official launch of Sara™, a secure period tracking app designed to empower users with personalized reproductive health insights.

How Comma Is Modernizing Reproductive Health Care

Comma is a reproductive health company dedicated to revolutionizing period care and modernizing reproductive health care through cutting-edge technology, sustainable products, and advanced diagnostics.

Founded by experts in reproductive health and cybersecurity, Comma is committed to delivering personalized, predictive, and secure healthcare solutions and modernizing reproductive health care.

At the heart of its innovation is Sara™, a hyper-secure period tracking app designed to protect user data with HIPAA-based privacy standards.

Sara™ empowers users to track their menstrual health, identify patterns, and connect with trusted care providers—all while ensuring the highest level of data privacy and autonomy, securely modernizing reproductive health care.

Beyond software, Comma is reshaping menstrual care with biodegradable period products and groundbreaking research into menstrual blood diagnostics.

With a mission to transform reproductive health, one period at a time, Comma is building a safer, smarter, and more sustainable future for menstrual care.

Secure, Predictive Reproductive Health Technology

With reproductive rights facing uncertainty, Comma aims to set a new standard in menstrual health by integrating secure technology and sustainable consumer products.

Led by a team of reproductive health and cybersecurity experts, the company has spent two years developing cutting-edge technology and consumer products that prioritize autonomy, security, and innovation.

After successfully completing the Techstars Physical Health accelerator program in 2023, Comma attracted a diverse group of investors, with more than 50% of its seed investors being women—a testament to its mission of centering those most impacted by reproductive health challenges.

"Comma is approaching menstrual health in a holistic way that hasn't been done before in the consumer products and technology space," said Trey Bowles, Managing Director of Techstars Physical Health. "We're proud to invest in a more secure, sustainable future through this partnership."

Read the full article about modernizing reproductive health at Causeartist.